Professors Mark Pierce and Prabhas Moghe were awarded a 1-year, $154,769 grant to advance a novel imaging contrast agent developed at Rutgers toward commercial adoption. The award, from the NIH’s C3i program, will allow the team to develop methods to synthesize infrared light-emitting nanocomposites at commercial scales. The nanocomposites can be used to highlight specific tissues within the body and are expected to find applications in preclinical imaging for drug discovery and in image-guided surgical resection of tumors.